Factors Affecting Mortality and Morbidity of Patients With Cirrhosis Hospitalized for Spontaneous Bacterial

Fatih Ensaroğlu1, Murat Korkmaz, Ali Ümit Geçkil

  • 1From the Department of Gastroenterology, Baskent University Faculty of Medicine, Ankara, Turkey.

Abstract

Insights

Spontaneous bacterial peritonitis (SBP) is a common infection in cirrhosis patients. This study found that advanced liver disease (Child-Pugh C) significantly increases SBP mortality, while albumin treatment showed no impact.

Area of Science:

  • Hepatology
  • Infectious Diseases
  • Critical Care Medicine

Background:

  • Spontaneous bacterial peritonitis (SBP) is a frequent complication in hospitalized cirrhosis patients, with a 9% prevalence and a 10% annual incidence.
  • SBP carries a 50% mortality rate if untreated and lacks established predictive parameters for mortality.
  • Identifying factors influencing SBP mortality is crucial for improving patient outcomes.

Purpose of the Study:

  • To analyze mortality predictors in cirrhotic patients diagnosed with spontaneous bacterial peritonitis.
  • To evaluate the impact of treatments, including albumin, on SBP-related mortality.

Main Methods:

  • Retrospective analysis of 29 patients with cirrhotic ascites infection treated between 1996 and 2013.
  • Data collected included demographics, paracentesis findings, clinical course, and treatment outcomes.
  • Patients were on the deceased-donor liver transplant waiting list.

Main Results:

  • The study group comprised 72.4% males, with an average age of 46.6 years.
  • Most patients had advanced liver disease (55.2% Child-Pugh C) and a MELD score of 17 ± 4.1.
  • Mortality was 81.3% in Child-Pugh C patients; albumin treatment did not significantly affect mortality.

Conclusions:

  • Advanced liver disease (Child-Pugh C) is strongly associated with increased SBP mortality.
  • Contrary to common clinical belief, albumin treatment did not demonstrate a significant impact on mortality in this patient cohort.
  • Chronic renal failure, liver graft surgery, and hepatocellular cancer were not significant mortality predictors in this study.

Related Concept Videos

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
1.6K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.6K
Peritoneal Dialysis III: Nursing Management01:25

Peritoneal Dialysis III: Nursing Management

Peritoneal dialysis, or PD, utilizes the peritoneal membrane as a filter to eliminate excess fluid and waste products. Effective nursing management is essential for ensuring patient safety, preventing complications, and promoting optimal function of the peritoneal dialysis process.Assessment and MonitoringNurses must thoroughly assess the patient before, during, and after each dialysis session. Regular monitoring includes vital signs, daily weight, fluid intake and output, and laboratory values...
1.4K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
335
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
1.1K
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.4K